Cargando…

Subclinical Atherosclerosis in Primary Sjögren's Syndrome: Does Inflammation Matter?

Sjögren's syndrome (SS) is a systemic autoimmune disease mainly characterized by inflammatory involvement of exocrine gland. Atherosclerosis is a complex process leading to plaque formation in arterial wall with subsequent cardiovascular (CV) events. Recently, numerous studies demonstrated that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bartoloni, Elena, Alunno, Alessia, Cafaro, Giacomo, Valentini, Valentina, Bistoni, Onelia, Bonifacio, Angelo Francesco, Gerli, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499202/ https://www.ncbi.nlm.nih.gov/pubmed/31110500 http://dx.doi.org/10.3389/fimmu.2019.00817

Ejemplares similares

Insulin-Like Growth Factor Binding Protein 6 in Rheumatoid Arthritis: A Possible Novel Chemotactic Factor?
por: Alunno, Alessia, et al.
Publicado: (2017)

Exploring the Link between Plasma Levels of PCSK9, Immune Dysregulation and Atherosclerosis in Patients with Primary Sjögren’s Syndrome
por: Bianconi, Vanessa, et al.
Publicado: (2023)

Telocytes in minor salivary glands of primary Sjögren’s syndrome: association with the extent of inflammation and ectopic lymphoid neogenesis
por: Alunno, Alessia, et al.
Publicado: (2015)

Emerging of a new CD3(+)CD31(H)CD184(+) tang cell phenothype in Sjögren’s syndrome induced by microencapsulated human umbilical cord matrix-derived multipotent stromal cells
por: Montanucci, Pia, et al.
Publicado: (2023)

T Regulatory and T Helper 17 Cells in Primary Sjögren's Syndrome: Facts and Perspectives
por: Alunno, Alessia, et al.
Publicado: (2015)

Interferon gamma-inducible protein 16 in primary Sjögren’s syndrome: a novel player in disease pathogenesis?
por: Alunno, Alessia, et al.
Publicado: (2015)

Methotrexate improves endothelial function in early rheumatoid arthritis patients after 3 months of treatment
por: Cafaro, Giacomo, et al.
Publicado: (2022)

Balance between Regulatory T and Th17 Cells in Systemic Lupus Erythematosus: The Old and the New
por: Alunno, Alessia, et al.
Publicado: (2012)

Mobilization of lymphatic endothelial precursor cells and lymphatic neovascularization in primary Sjögren's syndrome
por: Alunno, Alessia, et al.
Publicado: (2016)

Altered Immunoregulation in Rheumatoid Arthritis: The Role of Regulatory T Cells and Proinflammatory Th17 Cells and Therapeutic Implications
por: Alunno, Alessia, et al.
Publicado: (2015)

Cardiovascular Involvement in Sjögren’s Syndrome
por: Atzeni, Fabiola, et al.
Publicado: (2022)

Targeting Inflammation to Prevent Cardiovascular Disease in Chronic Rheumatic Diseases: Myth or Reality?
por: Bartoloni, Elena, et al.
Publicado: (2018)

Role of regulatory T cells in rheumatoid arthritis: facts and hypothesis
por: Alunno, Alessia, et al.
Publicado: (2010)

Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren’s syndrome minor salivary glands
por: Carubbi, Francesco, et al.
Publicado: (2019)

Peripheral Nervous System Involvement in Sjögren’s Syndrome: Analysis of a Cohort From the Italian Research Group on Sjögren’s Syndrome
por: Cafaro, Giacomo, et al.
Publicado: (2021)

The Impact of SARS-CoV-2 Outbreak on Primary Sjögren's Syndrome: An Italian Experience
por: Carubbi, Francesco, et al.
Publicado: (2020)

Expansion of regulatory GITR(+)CD25(low/-)CD4(+) T cells in systemic lupus erythematosus patients
por: Nocentini, Giuseppe, et al.
Publicado: (2014)

Lymphoma and Lymphomagenesis in Primary Sjögren’s Syndrome
por: Alunno, Alessia, et al.
Publicado: (2018)

Celiac Disease Prevalence Is Increased in Primary Sjögren’s Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study
por: Bartoloni, Elena, et al.
Publicado: (2019)

The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19
por: Perricone, Carlo, et al.
Publicado: (2020)

Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective study
por: Bizzaro, Nicola, et al.
Publicado: (2013)

Primary Sjögren's syndrome as independent risk factor for subclinical atherosclerosis
por: Novella-Navarro, Marta, et al.
Publicado: (2022)

The Microbial Capsular Polysaccharide Galactoxylomannan Inhibits IL-17A Production in Circulating T Cells from Rheumatoid Arthritis Patients
por: Pericolini, Eva, et al.
Publicado: (2013)

Drugs in induction and treatment of idiopathic inflammatory myopathies
por: Iaccarino, Luca, et al.
Publicado: (2014)

Antioxidant and Ex Vivo Immune System Regulatory Properties of Boswellia serrata Extracts
por: Beghelli, Daniela, et al.
Publicado: (2017)

Immune-Mediated Inflammation Promotes Subclinical Atherosclerosis in Recent-Onset Psoriatic Arthritis Patients without Conventional Cardiovascular Risk Factors
por: Kolliker Frers, Rodolfo A., et al.
Publicado: (2018)

Diet in Rheumatoid Arthritis versus Systemic Lupus Erythematosus: Any Differences?
por: Alunno, Alessia, et al.
Publicado: (2021)

Editorial: Management of Sjögren's Syndrome
por: Alunno, Alessia, et al.
Publicado: (2022)

COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy
por: Perricone, Carlo, et al.
Publicado: (2020)

Contribution of Janus-Kinase/Signal Transduction Activator of Transcription Pathway in the Pathogenesis of Vasculitis: A Possible Treatment Target in the Upcoming Future
por: Bursi, Roberto, et al.
Publicado: (2021)

Irisin as a Novel Biomarker of Subclinical Atherosclerosis, Cardiovascular Risk and Severe Disease in Axial Spondyloarthritis
por: Remuzgo-Martínez, Sara, et al.
Publicado: (2022)

Subclinical atherosclerosis and impaired bone health in patients with primary Sjogren’s syndrome: prevalence, clinical and laboratory associations
por: Gravani, Fotini, et al.
Publicado: (2015)

Maraviroc Intensification Modulates Atherosclerotic Progression in HIV-Suppressed Patients at High Cardiovascular Risk. A Randomized, Crossover Pilot Study
por: Francisci, Daniela, et al.
Publicado: (2019)

Impact of cardiovascular and immunologic variables on subclinical carotid atherosclerosis in subjects with anti-phospholipid antibodies
por: Di Minno, Matteo Nicola Dario, et al.
Publicado: (2018)

Biomarkers and Diagnostic Testing for Renal Disease in Sjogren's Syndrome
por: Ramponi, Giacomo, et al.
Publicado: (2020)

Neuro-Sjögren: Peripheral Neuropathy With Limb Weakness in Sjögren's Syndrome
por: Seeliger, Tabea, et al.
Publicado: (2019)

Plasma Sphingolipid Profile Associated With Subclinical Atherosclerosis and Clinical Disease Markers of Systemic Lupus Erythematosus: Potential Predictive Value
por: Hammad, Samar M., et al.
Publicado: (2021)

Intravenous Immunoglobulins at the Crossroad of Autoimmunity and Viral Infections
por: Perricone, Carlo, et al.
Publicado: (2021)

Autoantibodies Profile in the Sera of Patients with Sjogren]s Syndrome: The ANA Evaluation—A Homogeneous, Multiplexed System
por: Gilburd, Boris, et al.
Publicado: (2004)

Fat and inflammation: adipocyte-myeloid cell crosstalk in atherosclerosis
por: Mazitova, Aleksandra M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a4q1mlftivg0gmuv1cu605utbc